Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04000282
Title First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Investigational Site Number :8400002 Duarte California 91010 United States Details
Investigational Site Number :8400003 Boston Massachusetts 02115 United States Details
Investigational Site Number :8400005 Rochester Minnesota 55905 United States Details
Investigational Site Number :8400006 Chapel Hill North Carolina 27599 United States Details
Investigational Site Number :8400004 Milwaukee Wisconsin 53226 United States Details
Investigational Site Number :2030002 Brno 62500 Czechia Details
Investigational Site Number :2030003 Ostrava - Poruba 70852 Czechia Details
Investigational Site Number :2030001 Praha 2 12808 Czechia Details
Investigational Site Number :2500001 TOULOUSE Cedex 9 31059 France Details
Investigational Site Number :3000001 Athens 11528 Greece Details
Investigational Site Number :7240002 Hospitalet de Llobregat Castilla Y León 08908 Spain Details
Investigational Site Number :7240001 Salamanca 37007 Spain Details
Investigational Site Number :1580002 Taichung 40447 Taiwan Details
Investigational Site Number :1580001 Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field